Neuberger Berman Group’s Ascendis Pharma A/S ASND Stock Holding History

Neuberger Berman Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.1M	Buy	+142,705	New	+$33.3M	0.03%	571
2025 Q4	–	Sell	-21,049	Closed	-$4.18M	–	2122
2025 Q3	$4.18M	Sell	21,049 -2,185	-9%	-$408K	﹤0.01%	1005
2025 Q2	$4.01M	Sell	23,234 -23,096	-50%	-$3.76M	﹤0.01%	1019
2025 Q1	$7.22M	Buy	46,330 +8,201	+22%	+$1.17M	0.01%	848
2024 Q4	$5.25M	Sell	38,129 -1,633	-4%	-$215K	﹤0.01%	953
2024 Q3	$5.94M	Buy	39,762 +9,466	+31%	+$1.28M	﹤0.01%	909
2024 Q2	$4.13M	Buy	+30,296	New	+$4.12M	﹤0.01%	946
2021 Q2	–	Sell	-190,900	Closed	-$24.6M	–	1754
2021 Q1	$24.6M	Buy	190,900 +60,400	+46%	+$9.18M	0.02%	630
2020 Q4	$21.8M	Buy	130,500 +2,500	+2%	+$413K	0.02%	620
2020 Q3	$19.8M	Buy	128,000 +22,000	+21%	+$3.16M	0.02%	583
2020 Q2	$15.7M	Buy	106,000 +46,500	+78%	+$6.38M	0.02%	622
2020 Q1	$6.7M	Sell	59,500 -5,169	-8%	-$672K	0.01%	743
2019 Q4	$9M	Buy	+64,669	New	+$7.18M	0.01%	763
2018 Q2	–	Sell	-14,000	Closed	-$916K	–	1703
2018 Q1	$916K	Buy	+14,000	New	+$787K	﹤0.01%	1201

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Neuberger Berman Group's ASND Position: Q2 2026 in Review

Neuberger Berman Group opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 142,705 shares worth $38.1M. The stake represents 0.03% of the portfolio and ranks #571 among its holdings. This is a return to the name: Neuberger Berman Group previously reported a position in ASND as recently as Q3 2025.

Neuberger Berman Group first reported a position in ASND in Q1 2018 and has held it in 14 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Neuberger Berman Group held 142,705 shares of Ascendis Pharma A/S worth $38.1M as of Q2 2026.
Ascendis Pharma A/S was a new Neuberger Berman Group position in Q2 2026.
Ascendis Pharma A/S made up 0.03% of Neuberger Berman Group's portfolio in Q2 2026, its #571 holding.
Neuberger Berman Group first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 14 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.